| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5597957 | Annals of Vascular Surgery | 2017 | 36 Pages |
Abstract
Paclitaxel-eluting stents do not seem to provide benefits in terms of clinical and morphological outcomes for TASC C/D lesions compared to BMS.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Pierre-Alexandre Vent, Adrien Kaladji, Jean-Michel Davaine, Béatrice Guyomarch, Philippe Chaillou, Alain Costargent, Thibaut Quillard, Yann Gouëffic,